- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vivanza Biosciences Ltd is in the business of Pharmaceutical ProductsBusiness Overview: Vivanza Biosciences Limited is a specialty pharma company focused on commercializing novel and generic pharmaceuticals, developing oral drug delivery systems, and having expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections
Vivanza Biosciences has announced its 44th Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 3:30 P.M. via video conference. The company has dispatched the Annual Report for FY 2025-26 to shareholders. Remote e-voting will be available from September 8, 2026, 9:00 a.m. to September 10,...
Vivanza Biosciences Limited has confirmed that a statement of deviation or variation from fund utilization is not applicable to the company. This is because the company has not recently raised any new funds through public issues, rights issues, or preferential issues. This clarification simplifies compliance reporting requirements and indicates that...